In the multivariable analysis, low CD73 expression in tumor cells showed a significantly reduced risk of progression (HR: 0.40; 95% CI: [0.19, 0.85], p = 0.014) (Supplementary Material Table S8). This evidence concerns the gene NT5E and neoplasm.